Marksans Pharma Limited has informed the Exchange about Options to purchase securities under Marksans Employees Stock Option Scheme 2024 ( Scheme )
MARKSANS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Marksans Pharma has granted 4 lakh stock options to certain eligible employees of the company and its subsidiaries under the Marksans Employees Stock Option Scheme 2024. The options carry an exercise price of Rs. 10 per share (face value Re. 1) and have a vesting period of 1 year from the grant date of September 24, 2025. Once vested, employees have 2 years to exercise the options. The scheme was approved by shareholders at the AGMs held on September 24, 2024 and August 8, 2025, and received in-principle approval from BSE and NSE in September 2025.
This is a routine ESOP grant that will lead to mild dilution of existing shareholders once the options are exercised, but it also serves to align employee interests with shareholder value creation. The low exercise price of Rs. 10 (vs. market price) is a meaningful benefit for employees, and the resulting equity issuance is small relative to overall share capital.